Table 2.
Standardized 5- and 10-Year Cumulative Incidence of Mortality Under no Intervention and 3 Dynamic Treatment Plans With a 6-Month Grace Period Among 3532 Patients Who Entered Care Between 1 January 1998 and 31 December 2013 at 8 US Clinical Sites, Followed for Death for Up to 10 Years
| Treatment Plan | 5-year |
10-year |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mortality | RR | 95% CI | RD | 95% CI | Mortality | RR | 95% CI | RD | 95% CI | |
| No intervention | 5.45 | 12.60 | ||||||||
| All ages | ||||||||||
| 500 cells/mm3 | 4.63 | 1 | 0 | 10.80 | 1 | 0 | ||||
| 350 cells/mm3 | 5.30 | 1.15 | 1.05, 1.26 | 0.67 | .23, 1.11 | 11.66 | 1.08 | 1.00, 1.16 | 0.87 | .07, 1.67 |
| 200 cells/mm3 | 6.17 | 1.33 | 1.15, 1.54 | 1.54 | .72, 2.36 | 13.51 | 1.25 | 1.08, 1.44 | 2.71 | .92, 4.50 |
| 18 to 34 years of age | ||||||||||
| 500 cells/mm3 | 2.11 | 1 | 0 | 6.11 | 1 | 0 | ||||
| 350 cells/mm3 | 2.22 | 1.05 | .87, 1.27 | 0.11 | −.33, .55 | 6.08 | 1.00 | .87, 1.15 | −0.03 | −.83, .77 |
| 200 cells/mm3 | 2.45 | 1.16 | .84, 1.60 | 0.34 | −.40, 1.08 | 6.25 | 1.02 | .78, 1.33 | 0.14 | −1.48, 1.76 |
| 35 to 44 years of age | ||||||||||
| 500 cells/mm3 | 5.09 | 1 | 0 | 11.43 | 1 | 0 | ||||
| 350 cells/mm3 | 5.51 | 1.08 | .95, 1.22 | 0.42 | −.23, 1.07 | 12.42 | 1.09 | .99, 1.20 | 0.99 | −.13, 2.11 |
| 200 cells/mm3 | 5.76 | 1.13 | .91, 1.41 | 0.67 | −.59, 1.93 | 13.59 | 1.19 | 1.98, 1.45 | 2.15 | −.39, 4.69 |
| 45 to 65 years of age | ||||||||||
| 500 cells/mm3 | 9.17 | 1 | 0 | 19.29 | 1 | 0 | ||||
| 350 cells/mm3 | 11.28 | 1.23 | 1.08, 1.40 | 2.11 | .80, 3.42 | 21.60 | 1.12 | 1.01, 1.25 | 2.30 | .23, 4.37 |
| 200 cells/mm3 | 14.50 | 1.58 | 1.31, 1.90 | 5.33 | 3.15, 7.51 | 28.07 | 1.45 | 1.21,1.71 | 8.78 | 5.89, 13.90 |
Abbreviations: CI, confidence interval; RD, risk difference; RR, risk ratio.